These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 1969453)

  • 1. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma.
    Browning JL; Androlewicz MJ; Ware CF
    J Immunol; 1991 Aug; 147(4):1230-7. PubMed ID: 1714477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    Scheurich P; Thoma B; Ucer U; Pfizenmaier K
    J Immunol; 1987 Mar; 138(6):1786-90. PubMed ID: 3029221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
    Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
    J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.
    Ware CF; Crowe PD; Vanarsdale TL; Andrews JL; Grayson MH; Jerzy R; Smith CA; Goodwin RG
    J Immunol; 1991 Dec; 147(12):4229-38. PubMed ID: 1661312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
    J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S; Fager G; Hansson GK
    Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
    J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of lymphotoxin (LT), lymphotoxin-beta (LT-beta), and TNF-alpha in murine T cell clones activated through the TCR.
    Millet I; Ruddle NH
    J Immunol; 1994 May; 152(9):4336-46. PubMed ID: 8157957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells.
    Robinet E; Branellec D; Termijtelen AM; Blay JY; Gay F; Chouaib S
    J Immunol; 1990 Jun; 144(12):4555-61. PubMed ID: 2161875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
    Iwamoto S; Shibuya I; Takeda K; Takeda M
    Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.